BioSpace News Archive

Masimo (NASDAQ: MASI) announced today that St. Luke’s University Health Network (SLUHN) is one of the first institutions worldwide to use Masimo SafetyNet™ to monitor in-hospital patients, as the network seeks innovative solutions to care for the surge of patients infected by COVID-19.

The MD1 Program, the world’s largest provider of EMS physicians supporting EMTs, paramedics, firefighters and police on the front lines of the COVID-19 pandemic, announced that it has received a $25,000 grant from the Healthcare Foundation of New Jersey.

Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, today announced that it has hired Robert Pietrusko, PharmD, as Chief Regulatory and Quality Officer.

THREAD, an innovative technology provider that enables decentralized clinical research with Virtual Visits and eCOA, is partnering with its biopharma and contract research organization (CRO) customers through a specialized offering to rapidly support study-specific COVID-19 risk mitigation plans.

Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today announced that Don Haut, PhD, has been appointed its Chief Business Officer to oversee business development strategy and execution. “

Marrone Bio Innovations Inc. announced that Pacesetter™, a recently approved bio-based plant health product, is now available to corn, soybean and wheat growers in the United States.

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, today announced that it is providing GIAPREZA™ (angiotensin II) for named patient emergency use in patients with septic shock due to COVID-19 at University Hospital Münster in Germany. GIAPREZA is being made available for named patient emer

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has gone live with an initial phase of its digital pathology solution at New York’s Hospital for Special Surgery (HSS), the world’s leading academic medical center focused on musculoskeletal health.

As the global health crisis quickly spreads in the United States, officials face the daunting task of treating patients in person and monitoring their progress.

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has licensed a new method to help increase plant gene editing efficiency from the University of Minnesota.